In this issue:
ASCO thoracic oncology guidelines in development
Systemic therapy for SCLC: ASCO-Ontario Health guideline
PAPILLON: Amivantamab/chemo combo bests chemo in EGFR ex20ins+ NSCLC
Chemo-free combo has durable activity in EGFR-mutated NSCLC
FLAURA2 supports osimertinib + chemo for unresectable EGFRmutated advanced NSCLC
Novel combo promising for BRAF V600+ NSCLC
Novel regulatory approvals across the globe
Registration opens for ELCC 2024
Australian Cancer Plan released during Lung Cancer Awareness Month
Stopping smoking at lung cancer diagnosis improves prognosis
Risk–based lung cancer screening reduces racial disparities in the US
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)